- Advertisement -

Editas’ Current and Future CEOs Discuss CMO Search, EDIT-101, and Growth

In Part II of an exclusive interview with GEN Edge, O’Neill and Mullen discuss Editas’ search for a new chief medical officer to succeed...

The Benefit of Hands-On Experience in Biotechnology Graduate Programs – Azusa Pacific University

Biotechnology is not only an exciting career that covers a broad range of career fields engaged in advancing medical technology—it’s also a quickly growing...

RENACER: New national hospital network aims to advance research on brain metastases

Last January 25th, the bylaws of the National Brain Metastasis Network (or RENACER, its acronym in Spanish) were signed and the network's first meeting...

Advancing Liquid Biopsy Companion Diagnostics with a Novel Sequencing Initiative

Sponsored content brought to you by   The promise of precision oncology is being realized, with an array of targeted treatments and immunotherapies now available across...

Lonza Launches New Cell Line and MilliporeSigma Introduces Digital Reference Materials...

Lonza officials say the company’s new GS Effex® cell line is designed to help biotech firms develop more sophisticated therapeutic antibodies. Combined with good cell...

Deactivating specific protein with drugs reverses inflammation, scarring of liver in...

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore (NHCS) found that deactivating a specific protein - interleukin 11...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...